Publication Name	World Journal of Orthopedics
Manuscript ID	9462
Country	India

Received	2014-02-13 13:57
Peer-Review Started	2014-02-13 19:50
To Make the First Decision	2014-03-26 15:27
Return for Revision	2014-04-02 20:41
Revised	2014-04-10 22:08
Second Decision	2014-09-10 13:27
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-09-10 13:48
Articles in Press	2014-09-10 13:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-02-20 18:02
Publish the Manuscript Online	2015-03-19 18:29

ISSN	2218-5836 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Minireviews
Article Title	Is non-biological treatment of rheumatoid arthritis as good as biologics?
Manuscript Source	Invited Manuscript
All Author List	Jyoti Ranjan Parida, Durga Prasanna Misra, Anupam Wakhlu and Vikas Agarwal
Funding Agency and Grant Number
Corresponding Author	Dr. Vikas Agarwal, Additional Professor, Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, India. vikasagr@sgpgi.ac.in
Key Words	Rheumatoid arthritis; Disease modifying drugs; Biologics; Methotrexate; Sulfasalazine; Leflunomide; Cyclosporine; Hydroxychloroquine; Tumor necrosis factor; Remission; Radiologic outcome
Core Tip	In developing world cost of treatment remains a major concern. Recent evidences are emerging that support the equal efficacy of conventional disease modifying anti-rheumatic drugs (DMARDs) as compared to biological DMARDs. In this review we have presented evidences supporting conventional DMARDs in management of rheumatoid arthritis.
Publish Date	2015-03-19 18:29
Citation	Parida JR, Misra DP, Wakhlu A, Agarwal V. Is non-biological treatment of rheumatoid arthritis as good as biologics? World J Orthop 2015; 6(2): 278-283
URL	http://www.wjgnet.com/2218-5836/full/v6/i2/278.htm
DOI	http://dx.doi.org/10.5312/wjo.v6.i2.278

Full Article (PDF)	WJO-6-278.pdf
Full Article (Word)	WJO-6-278.doc
Manuscript File	9462-Review.docx
Answering Reviewers	9462-Answering reviewers.pdf
Copyright License Agreement	9462-Copyright assignment.pdf
Peer-review Report	9462-Peer review(s).pdf
Scientific Misconduct Check	9462-CrossCheck.jpg
Scientific Editor Work List	9462-Scientific editor work list.pdf